SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $311,508 | +109.4% | 30,570 | +86.4% | 0.01% | +133.3% |
| Q1 2023 | $148,775 | +48.7% | 16,403 | +17.6% | 0.00% | +50.0% |
| Q4 2022 | $100,043 | -62.4% | 13,953 | -65.8% | 0.00% | -71.4% |
| Q3 2022 | $266,000 | -35.4% | 40,751 | -52.3% | 0.01% | -36.4% |
| Q2 2022 | $412,000 | -16.3% | 85,462 | -1.4% | 0.01% | 0.0% |
| Q1 2022 | $492,000 | +13.1% | 86,635 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $435,000 | -24.5% | 86,635 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $576,000 | -24.5% | 86,635 | -30.6% | 0.02% | -36.0% |
| Q2 2021 | $763,000 | -14.7% | 124,827 | -7.2% | 0.02% | -26.5% |
| Q1 2021 | $895,000 | +12.3% | 134,516 | -10.7% | 0.03% | +13.3% |
| Q4 2020 | $797,000 | -29.7% | 150,699 | -1.0% | 0.03% | -56.5% |
| Q3 2020 | $1,134,000 | +1.2% | 152,241 | +0.0% | 0.07% | -10.4% |
| Q2 2020 | $1,120,000 | +31.1% | 152,211 | +31.9% | 0.08% | +8.5% |
| Q1 2020 | $854,000 | – | 115,388 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,207,009 | $15,713,904 | 7.44% |
| 5AM Venture Management, LLC | 1,200,647 | $8,548,607 | 2.46% |
| Worth Venture Partners, LLC | 539,665 | $3,842,415 | 2.28% |
| COWEN AND COMPANY, LLC | 1,795,647 | $12,785,006 | 0.90% |
| Orbimed Advisors | 5,559,528 | $39,583,839 | 0.84% |
| Rubric Capital Management LP | 2,713,287 | $19,318,603 | 0.72% |
| AlphaCentric Advisors LLC | 125,000 | $890,000 | 0.50% |
| RTW INVESTMENTS, LP | 3,297,843 | $23,480,642 | 0.50% |
| Tejara Capital Ltd | 101,414 | $722,068 | 0.41% |
| Leucadia National | 745,550 | $5,308,316 | 0.05% |